Treatment in patients with osteoarthritis at different sites: Place of slow-acting drugs
The main goal of osteoarthritis (OA) treatment is to perform rational analgesic and anti-inflammatory therapy, to slow down the progression of the disease, and to preserve quality of life in patients. The performance of analgesic therapy in the elderly is impeded by the presence of a concomitant dis...
Saved in:
Main Authors: | N. V. Chichasova, G. R. Imametdinоva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2015-06-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/625 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
by: E. V. Zonova
Published: (2021-04-01) -
From misconceptions to reasonable osteoarthritis patients therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-07-01) -
Cardiovascular safety and efficacy of the combined symptomatic slow-acting drug glucosamine and chondroitin sulfate in patients with gonarthrosis
by: A. P. Rebrov, et al.
Published: (2016-06-01) -
Osteoarthritis background therapy: current view on the glucosamine and chondroitin therapy
by: L. I. Alekseeva, et al.
Published: (2021-04-01) -
The efficacy and tolerability of the slow-acting combined agent glucosamine and chondroitin sulfate in gonarthrosis patients tacking no nonsteroidal anti-inflammatory drugs
by: A. P. Rebrov, et al.
Published: (2016-01-01)